James Anderson, a partner at Scottish money manager Baillie Gifford, has personified growth-stock investing during his 39 years with the firm. He was an early backer of Amazon.com, Tesla, and other “e...
Tag: Moderna
Ted Cruz Trolls Mr. T Covid-19 Face Mask Tweet, Here’s The Reaction
On Wednesday, Mr. T tweeted out, “I just received my 2nd Moderna booster vaccine, and I feel good! I … [+] am still going to wear my mask and keep my distance because the virus ain’t over, Fool!...
We Cannot ‘Boost Our Way Out’ Of The Covid Pandemic, Experts Warn
Topline U.S. officials greenlit second booster doses of the Pfizer-BioNTech and Moderna Covid vaccines last week in an effort to bolster waning immunity ahead of a potential surge of cases driven by t...
CDC Advises To Mix J&J Covid Vaccine With Pfizer Or Moderna Booster
Topline The Centers for Disease Control and Prevention on Tuesday recommended that people who have received two shots of a Covid-19 vaccine produced by Johnson & Johnson and Janssen follow up with...
Is Moderna a better buy compared to Pfizer?
Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) has been highly popular stocks since the outbreak of COVID-19. Their development of vaccines against the virus results in significant gains for th...
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...
3 Top S&P 500 Stock Market Gainers Today: Energy Strong As Moderna, Etsy Skid
Coterra Energy (CTRA), Lumen Technologies (LUMN) and Kinder Morgan (KMI) were the top three S&P 500 index gainers on the stock market today. Moderna (MRNA), Epam Systems (EPAM) and Etsy (ETSY) we...
Moderna Stock Plunges Despite ‘Vaccine Day’ Touting 31 New Shots And $21 Billion In Sales—Here’s Why
Topline Though Moderna hosted an investor seminar Thursday touting the firm’s growing vaccine pipeline and climbing sales, shares of the Cambridge, Mass.-based biotech firm plunged on Friday as ...
Moderna CEO Stephane Bancel on second Covid vaccine booster shots
Moderna CEO Stephane Bancel told CNBC on Thursday the drugmaker wanted to provide U.S. regulators “flexibility” in determining eligibility for a fourth Covid vaccine dose. Moderna submitte...
Moderna vaccine for young kids up to 44% effective against omicron
With her husband Stephen by her side Erin Shih hugs her children Avery 6, and Aidan, 11, after they got their second Moderna COVID-19 vaccines at Kaiser Permanente Los Angeles Medical Center on Friday...
Do You Need A Second Covid Booster Shot? Experts Are Divided.
Topline Amid evidence of waning immunity and new Covid surges across Europe and Asia, a growing number of countries have started rolling out fourth doses of coronavirus vaccines—or are debating doing ...
Moderna Stock Rises On Booster Request; But Is A Fourth Shot Needed?
Moderna (MRNA) asked the Food and Drug Administration to authorize its Covid booster for all adults — a much wider request than Pfizer‘s (PFE) — and Moderna stock popped Friday. X The request is...
FedEx, GameStop, Moderna and more
Check out the companies making headlines before the bell: FedEx (FDX) – FedEx earned an adjusted $4.59 per share for its latest quarter, missing estimates by 5 cents, though the delivery service’...
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the pandemic — averaging roughly $3.6 million a week...
Moderna CEO’s golden parachute soared by hundreds of millions over the pandemic
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna’s board of directors approved a golden parachute for CEO Stephane Bancel worth more than $926 million at the end of last year, u...
Moderna Erases $52 Billion in Value as Rout Deepens to 50%
(Bloomberg) — Moderna Inc.’s shares have dropped 50% this year as investors pulled back from Covid-19 healthcare stocks and staged a broader rotation out of growth names. Most Read from Bloomber...
Moderna reaches preliminary agreement to build Covid vaccine manufacturing plant in Africa
A health official prepares a syringe with the Moderna Covid-19 vaccine prior to administering it during a mass Covid-19 vaccination drive in Nairobi on September 17, 2021. Simon Maina | AFP | Getty Im...
Pfizer, Moderna project $51 billion in combined vaccine sales this year
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Dado Ruvic | Reuters Pfizer and Moderna expect $51 bill...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
Moderna beat expectations in Q4 results. Will this stop the bleeding?
Moderna Inc. (NASDAQ:MRNA) released the fourth quarter and annual results. Results show better than expected performance. Revenues rose to $7.2 billion and the EPS to $11.29. Moderna also gave revenue...
Live Nation, Moderna, Booking Holdings and more
An illustration of a Live Nation Entertainment logo is seen on a smartphone and a pc screen. SOPA Images | Getty Images Check out the companies making headlines in midday trading Thursday. Live Natio...
Should I buy Moderna shares after strong Q4 results?
Moderna Inc. (NASDAQ: MRNA) shares advanced more than 15% after the company reported a quarterly report that blew away Wall Street analysts’ estimates. The company’s management has authorized a new sh...
Moderna says Covid is entering an endemic phase, but annual vaccines will be needed
Maryland National Guard Specialist James Truong (L) administers a Moderna coronavirus vaccine at CASA de Maryland’s Wheaton Welcome Center on May 21, 2021 in Wheaton, Maryland. Chip Somodevilla ...
Moderna Stock Surges On Q4 Earnings Beat, 2022 Vaccine Sales Boost
Updated at 10:06 am EST Moderna (MRNA) – Get Moderna, Inc. Report shares surged Thursday after the drugmaker posted must stronger-than-expected fourth quarter earnings, while boosting its full-...
Moderna (MRNA) Q4 2021 earnings
The Moderna Covid-19 vaccine is prepared for administration ahead of a free distribution of over the counter rapid Covid-19 test kits to people receiving their vaccines or boosters at Union Station in...
Moderna to Post Multi-Fold Jump in Q4 Earnings and Revenue
Moderna, the biotech company focused on drug discovery, is expected to report its fourth-quarter earnings of $8.62 per share, which represents year-over-year growth of over 1,340% from a loss of -$0.6...
Healthcare Is Slowly Moving Out Of Hospitals & Into Homes
The Covid-19 coronavirus pandemic has reshaped society’s understanding of ideal healthcare delivery. During the height of the pandemic and amidst sweeping social isolation measures, billions of people...